IRCT20091012002576N30招募中2 期
Evaluation of efficacy of subendometrial Growth hormone injection for FET cycle of RIF patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 44 years（—）
- 性别
- Female
入选标准
- •RIF patients
- •Have good quality embryo
- •Having signed informed consent
排除标准
- •Severe male infertility
- •Uncontrolled hypothyroidism
- •User of corticosteroids
- •User of glucose control agents
- •Uterine malformations
- •Cavity distorting lesion
- •Severe endometriosis
- •Liver disease
- •Asherman syndrome
研究者
相似试验
已完成
不适用
Asymptomatic Increased endometrial thickness in postmenopausal women .risk factorsACTRN12617001137381nahed allam146
进行中（未招募）
不适用
A study to evaluate the effect on the endometrium of a new formulation containing 4 mg drospirenone (Drospirenone 4 mg film-coated tablet) administered over a period of 13 cycles. A monocentric, open, multiple dose trial in healthy female subjects at risk of pregnancyEUCTR2013-002300-13-BGCHEMO France
尚未招募
2 期
Efficacy of subendometrial PRP injection for FET cycle of RIF patientsInfertility.N97.8Female infIRCT20091012002576N29Tehran University of Medical Sciences60
已完成
不适用
Evaluation of the Efficacy of Growth Hormone, EndoSeal MTA Sealer, and Their Combination on Healing of Periapical PathosisGrowth HormoneNCT06433375Al-Azhar University28
尚未招募
不适用
Role of endometrial thickness, embryo grade and type of embryo transfer in pregnancy outcome in IVF cyclesCTRI/2022/03/040810Maulana Azad Medical College and associated Lok Nayak Hospital Delhi